Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems
Reach Out 2: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems
1 other identifier
interventional
500
1 country
1
Brief Summary
Emergency department visits provide an opportunity to identify people with undiagnosed, untreated, or uncontrolled high blood pressure. In Reach Out, we will test whether a mobile health intervention yields a greater reduction in blood pressure than usual care among individuals identified with high blood pressure during a safety-net emergency department visit. Subsequently, we will estimate the reduction in heart attack, stroke, and dementia if Reach Out were implemented across all U.S. safety-net emergency departments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jul 2024
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2024
CompletedFirst Posted
Study publicly available on registry
April 30, 2024
CompletedStudy Start
First participant enrolled
July 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2028
July 24, 2025
July 1, 2025
3.6 years
April 25, 2024
July 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in systolic blood pressure
Change in 6-month Systolic Blood Pressure (SBP)
6 month
Secondary Outcomes (2)
Change in diastolic blood pressure
6 month
BP Control (130/80mmHg)
6 month
Other Outcomes (5)
BP Control (140/90mmHg)
6 month
Initiation of antihypertensive medication
6 month
Change in antihypertensive medication
6 month
- +2 more other outcomes
Study Arms (2)
Usual Care Group
NO INTERVENTIONThe usual care group is standard of care. They will receive the standard ED discharge materials available as recommended by their ED physician. These materials recommend lifestyle changes, dietary changes, medication as directed, and follow-up with a PCP as directed.
REACH OUT
EXPERIMENTALREACH OUT messaging is based on BP control. Control is defined as SMBP \<135/85. Every 4 weeks SMBP measurements will be assessed and mHealth components will be escalated, de-escalated, or remain the same. If BP is controlled, SMBP prompts will be sent once a week and there will be no facilitated appointments. If BP is uncontrolled, SMBP prompts will be sent three times per week and facilitated provider scheduling and transportation will occur. Participants will have the option include a partner, friend, or family member with text-messaging capability who could support them on their BP journey. The partner will receive Reach Out materials and text messages to remind the participant to engage in SMBP and of their upcoming appointments (if uncontrolled).
Interventions
Physician appointment and transportation scheduling or none dependent on current BP control
Eligibility Criteria
You may not qualify if:
- Critical illness
- Unable to read English (\<1% at study site)
- Incarcerated
- Pregnant
- Pre-existing condition making 6-month follow-up unlikely
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- University of Michigancollaborator
- Ohio State Universitycollaborator
Study Sites (1)
Hurley Medical Center
Flint, Michigan, 48503, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
William Meurer, MD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 25, 2024
First Posted
April 30, 2024
Study Start
July 22, 2024
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
November 30, 2028
Last Updated
July 24, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Before completion of trial data collection.
Data in which direct and indirect identifiers have been removed will be made available through data-sharing website